Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

Businessweek Archives

Scandal In South Africa?


International Outlook: GLOBAL WRAPUP

SCANDAL IN SOUTH AFRICA?

South Africa's Public Protector is probing whether Deputy President Thabo Mbeki and Health Minister Nkosazana Zuma acted unethically by urging that research resume on an anti-AIDS drug, Virodene. The opposition Democratic Party claims Pretoria-based Cryopreservation Technologies offered the ruling African National Congress a 6% stake in a unit that would hold patents on the drug.

An investigator at the Public Protector's office says a company document shows a proposal to give shares was discussed internally. But a company official says no shares were ever offered to, nor was the idea discussed with, the ANC. Mbeki, Zuma, and the ANC all deny any wrongdoing, saying they tried to speed testing of the drug, banned by the Medicines Control Council because it contains a toxic industrial solvent, to help AIDS sufferers.EDITED BY JOHN TEMPLEMAN


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus